Defective N‐glycosylation in tumor‐infiltrating CD8+ T cells impairs IFN‐γ‐mediated effector function
暂无分享,去创建一个
R. Seong | Jungeun An | Soyeon Kim | Woojun Kim | Youngjin Lee | J. Jeong | Jinwoo Nah | Kyungsoo Park | Jieun Kim | H. Min
[1] S. Pinho,et al. Glycans as shapers of tumour microenvironment: A sweet driver of T‐cell‐mediated anti‐tumour immune response , 2022, Immunology.
[2] S. Tu,et al. Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments , 2021, Frontiers in Immunology.
[3] J. Reymond,et al. Substrate specificities and reaction kinetics of the yeast oligosaccharyltransferase isoforms , 2021, The Journal of biological chemistry.
[4] R. Kiessling,et al. Counteracting CAR T cell dysfunction , 2020, Oncogene.
[5] W. Lee,et al. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity , 2020, Experimental & Molecular Medicine.
[6] S. Erkeland,et al. Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation , 2020, PLoS pathogens.
[7] N. Callewaert,et al. Human T cell glycosylation and implications on immune therapy for cancer , 2020, Human vaccines & immunotherapeutics.
[8] X. Liu,et al. Large-scale public data reuse to model immunotherapy response and resistance , 2020, Genome Medicine.
[9] T. Toyofuku,et al. Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells , 2020, The Journal of Immunology.
[10] N. Taniguchi,et al. Oligosaccharyltransferase: A Gatekeeper of Health and Tumor Progression , 2019, International journal of molecular sciences.
[11] Chen Yan,et al. IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer , 2019, BMC Cancer.
[12] S. Berger,et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion , 2019, Nature.
[13] E. Wherry,et al. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.
[14] M. Kalady,et al. Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. , 2019, Cell metabolism.
[15] S. Pinho,et al. Glycans as Key Checkpoints of T Cell Activity and Function , 2018, Front. Immunol..
[16] G. Rabinovich,et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity , 2018, Nature.
[17] X. Liu,et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.
[18] D. Maresch,et al. An oligosaccharyltransferase from Leishmania major increases the N‐glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana , 2018, Plant biotechnology journal.
[19] Morihisa Fujita,et al. Construction of green fluorescence protein mutant to monitor STT3B‐dependent N‐glycosylation , 2018, The FEBS journal.
[20] R. Vijay,et al. Interleukin‐10 Directly Inhibits CD8+ T Cell Function by Enhancing N‐Glycan Branching to Decrease Antigen Sensitivity , 2018, Immunity.
[21] J. Whisstock,et al. Regulation of perforin activation and pre‐synaptic toxicity through C‐terminal glycosylation , 2017, EMBO reports.
[22] A. Yoshimura,et al. Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells. , 2017, Cell reports.
[23] I. Frazer,et al. Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.
[24] M. Pereira,et al. Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction , 2017, Cellular Physiology and Biochemistry.
[25] J. Wargo,et al. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.
[26] R. Schreiber,et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.
[27] Young Hwan Kim,et al. Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. , 2015, Carbohydrate research.
[28] A. Antebi,et al. Hexosamine pathway and (ER) protein quality control. , 2015, Current opinion in cell biology.
[29] H. Freeze,et al. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. , 2013, Human molecular genetics.
[30] H. Freeze,et al. A sensitive green fluorescent protein biomarker of N‐glycosylation site occupancy , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] P. Walter,et al. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.
[32] Christodoulos A. Floudas,et al. Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database , 2011, Scientific reports.
[33] L. Harrington,et al. Pronounced Virus-Dependent Activation Drives Exhaustion but Sustains IFN-γ Transcript Levels , 2010, The Journal of Immunology.
[34] Luis Serrano,et al. Correlation of mRNA and protein in complex biological samples , 2009, FEBS letters.
[35] Temple F. Smith,et al. Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses , 2009, Proceedings of the National Academy of Sciences.
[36] S. High,et al. Ribophorin I regulates substrate delivery to the oligosaccharyltransferase core , 2008, Proceedings of the National Academy of Sciences.
[37] Gang Wu,et al. Integrative Analyses of Posttranscriptional Regulation in the Yeast Saccharomyces cerevisiae Using Transcriptomic and Proteomic Data , 2008, Current Microbiology.
[38] DavidE . Goldberg,et al. Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans1 , 2006, The Journal of Immunology.
[39] S. Rosenberg,et al. Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells , 2003, The Journal of experimental medicine.
[40] Kristin A. Hogquist,et al. Sweet 'n' sour: the impact of differential glycosylation on T cell responses , 2002, Nature Immunology.
[41] A. Frey,et al. CD8+ Tumor-Infiltrating Lymphocytes Are Primed for Fas-Mediated Activation-Induced Cell Death But Are Not Apoptotic In Situ1 , 2001, The Journal of Immunology.
[42] S. Toyoshima,et al. Increased Degradation of Newly Synthesized Interferon-γ (IFN-γ) in Anti CD3-Stimulated Lymphocytes Treated with Glycoprotein Processing Inhibitors , 2000 .
[43] K Cantell,et al. Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma. , 1994, The Biochemical journal.